Quintrio
Home

TELEPHONE COMMUNICATIONS (NO RADIOTELEPHONE)

NextPlat Corp Common Stock

NXPL

NextPlat Corp is an e-commerce and healthcare company. The company operates in two segments: e-Commerce Operations involves acquiring and leasing an e-commerce platform; and Healthcare Operations provides TPA, data management, COVID-19 related diagnostics and vaccinations, prescription pharmaceuticals, and Others.

Last trade $7.63
Day change +$0.69 (+9.94%)
Day range $6.94 – $7.75
Volume 22,467
Market cap $19M

Open XNAS

Fundamentals

Key company ratios and reported financial statements.

Source: Massive.com

Key ratios

Valuation

Market capitalization
$18.8M
Price / earnings
—
Price / book
1.15×
Price / sales
0.39×
EV / sales
0.15×
EV / EBITDA
-1.13×

Profitability

Earnings per share
-$3.63
Return on assets
-34.33%
Return on equity
-60.07%
Dividend yield
0%

Liquidity and leverage

Debt / equity
0.01×
Current ratio
2.29×
Quick ratio
1.92×
Cash ratio
1.09×

Cash flow

Price / cash flow
—
Price / free cash flow
—
Free cash flow
-$4.57M

Ratios use trailing-twelve-month financials and market data as of Nov 16, 2026.

Financial statements

Income and cash flow amounts are for the period; balance sheets are point-in-time snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are displayed when available.

Income statement for NXPL, quarterly periods
Line itemQ2 FY2026 Jun 30, 2026Q1 FY2026 Mar 31, 2026Q4 FY2025 Dec 31, 2025Q3 FY2025 Sep 30, 2025Q2 FY2025 Jun 30, 2025Q1 FY2025 Mar 31, 2025Q4 FY2024 Dec 31, 2024Q3 FY2024 Sep 30, 2024
Revenue$11.88M$9.86M$12.81M$13.75M$13.24M$13.93M$16.23M$15.37M
Cost of revenue$7.19M$6.44M$10.98M$11.02M$10.36M$11.06M$13.5M$11.81M
Gross profit$4.69M$3.41M$1.83M$2.73M$2.88M$2.86M$2.73M$3.56M
Selling, general and administrative$4.74M$4.43M$5.16M$4.56M$4.54M$4.75M$4.81M$7.35M
Research and development$0$0$0$0$0$0$0$0
Total operating expenses$4.82M$4.52M$5.53M$4.72M$4.71M$4.95M$5.02M$11.56M
Operating income-$127K-$1.1M-$3.7M-$1.99M-$1.83M-$2.08M-$2.29M-$8M
Interest expense$0$0-$17K-$14K$0$0-$19K-$22K
Income before taxes-$96K-$1.13M-$5.16M-$2.21M-$1.76M-$1.93M-$2.44M-$7.62M
Income taxes$48K$0-$14K-$26K$31K$9K-$21K$45K
Net income-$144K-$1.13M-$5.15M-$2.19M-$1.79M-$1.94M-$2.42M-$7.66M
Net income attributable to common shareholders-$144K-$1.12M-$6.4M-$2.19M-$1.79M-$1.94M-$2.42M-$4.22M
EBITDA-$47K-$1.01M-$3.33M-$1.83M-$1.65M-$1.89M-$2.09M-$3.79M
Basic earnings per share-$0.05-$0.42-$2.27-$0.80-$0.69-$0.75-$0.93-$2.20
Diluted earnings per share-$0.05-$0.42-$2.27-$0.80-$0.69-$0.75-$0.93-$2.20

Recent news

Company coverage with links to the original publishers.

Publication times in UTC
Zacks Investment Research

PetMed (PETS) Reports Q2 Loss, Lags Revenue Estimates

PetMed (PETS) reported a quarterly loss of $0.31 per share, significantly worse than the consensus estimate of $0.11, representing a -181.82% earnings surprise. Revenue of $35.77 million also missed expectations. The company received a Zacks Rank #5 (Strong Sell) rating due to unfavorable estimate revisions. Shares have declined 60.9% year-to-date, and the Internet-Commerce industry ranks in the bottom 41% of sectors.

Benzinga

NextPlat Launches 50 State Nationwide Medication Fulfillment Capabilities, Supporting Healthcare Revenue Growth in 2026 and Beyond

NextPlat Corp announced a partnership with HealthWarehouse.com to enable nationwide prescription and over-the-counter medication fulfillment across all 50 U.S. states. The collaboration significantly expands NextPlat's healthcare footprint beyond Florida, where it currently generates over 70% of its $55 million annual revenue, and aims to accelerate geographic expansion and e-commerce growth in 2026.

Benzinga

NextPlat Expects Approximately $55 Million in 2025 Revenue and Reports Strong Sequential Momentum with Cost Reductions and Margin Expansion Expected into 2026

NextPlat Corp reported strong sequential momentum in Q4 2025 with expected $55 million in annual revenue. The company expects significant gross margin expansion of 20-25% in Q1 2026, driven by growth in higher-margin 340B healthcare services and contracted fulfillment. Cost reduction initiatives and operational efficiencies are underway, with management expecting meaningful reductions in operating losses by mid-2026.

Benzinga

NextPlat Issues CEO Shareholder Update Letter

NextPlat Corp provides an update on its strategic progress across healthcare services, communications, and e-commerce channels, highlighting cost reduction efforts, new contracts, and technology investments aimed at driving growth and profitability.

Dividends

Declared distributions and recorded event dates. Forecasts are not shown.

Updated daily

No declared upcoming dividend found.

No prior dividend records found.

Stock splits

Historical share-structure events and their execution dates.

Updated daily
Execution dateSplit ratioEvent type
Apr 13, 20261-for-10reverse split